Blog

At the 2026 Annual Meeting of the American Society of Clinical Oncology (ASCO), researchers from the Dana-Farber Cancer Institute presented groundbreaking findings that could redefine treatment...

As the annual meeting of the American Society of Clinical Oncology (ASCO) approaches, the Fred Hutch Cancer Center is poised to share groundbreaking advancements in the treatment of various cancers,...

At the recent ASCO 2026 conference, groundbreaking research emerged that could significantly change the way we understand and treat solitary fibrous tumors (SFTs). These rare tumors, while often...

Recent research presented at the ASCO 2026 conference sheds light on solitary fibrous tumors (SFTs), a rare type of cancer, highlighting genetic patterns that may predict tumor behavior. Conducted by...

In a groundbreaking study published recently, researchers have unveiled a new biomarker known as HAVCR1 that could transform the early detection and treatment of rare and aggressive brain, spinal...

Recent research published on May 21, 2026, has unveiled a groundbreaking discovery regarding the progression of precancerous lesions in the pancreas, shedding light on how these changes can evolve...

Recent research from the James P. Allison Institute at The University of Texas MD Anderson Cancer Center has unveiled a significant breakthrough in the treatment of metastatic castration-resistant...

In a significant stride toward enhancing our understanding of cancer, the Endocrine Society and Keystone Symposia are set to host their first joint conference in October. This gathering of...

The intersection of hormones and cancer is a critical area of research that is gaining momentum, particularly with the announcement of the first joint conference hosted by the Endocrine Society and...

In a significant boost for cancer research and care, the University of Texas MD Anderson Cancer Center has been awarded over $19 million by the Cancer Prevention and Research Institute of Texas...

In a groundbreaking study, researchers from Stony Brook Medicine and Yale School of Medicine have identified a protein known as K17 as a significant contributor to the resistance of pancreatic cancer...

Recent research led by a team from Stony Brook Medicine and Yale School of Medicine has unveiled a promising target in the ongoing battle against pancreatic cancer: a protein known as K17. This...

Recent advancements in cancer research have unveiled a new potential approach for treating aggressive brain tumors, particularly high-grade gliomas, which have historically posed significant...

Explore how MAMMAL connects gene expression, SMILES strings, proteins, and drug response prediction for cancer drug discovery and precision oncology research.

MAMMAL AI is a multimodal biomedical foundation model for drug discovery. Learn what Molecular Aligned Multi-Modal Architecture and Language means and why it matters.

Learn how to use MAMMAL, IBM Research's multimodal biomedical foundation model, for protein, small-molecule, gene-expression, and drug discovery research workflows.

Recent research from Wits University has sparked excitement in the cancer research community, revealing that the bacteria present in our saliva could serve as a crucial early warning sign for...

In a significant move towards advancing cancer research and improving patient care, the Association of American Cancer Institutes (AACI) is urging federal lawmakers to support the Knock Out Cancer...

In a significant move for cancer research, the Association of American Cancer Institutes (AACI) has expressed strong support for the Knock Out Cancer Act, a proposed legislation aimed at increasing...

Recent findings from a comprehensive study conducted by researchers at Houston Methodist have brought to light significant changes in breast cancer risk and outcomes for women across the United...